Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Inspirna, Inc.
AstraZeneca
Daiichi Sankyo
Oncology Institute of Southern Switzerland
Dana-Farber Cancer Institute